Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine for reduction of iron overload in patients with major thalassemia
IRCT2015080720715N2Phase 2Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of amlodipine in beta thalassemia major and iron overload, sponsored by Arak University of Medical Sciences. Started May 2015; status: completed.
02
Drugs
amlodipine
03
Conditions
beta thalassemia majoriron overload
Beyond the preview
Go deeper on IRCT2015080720715N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015080720715N2.